Waste Management (NYSE: WM) insiders sold approximately $25 million in stock following a surge to an all-time high in early 2026, yet institutional accumulation and a robust dividend yield signal a positive long-term outlook. With insiders holding only 0.18% of shares, their selling is unlikely to impact the stock’s trajectory, particularly as institutional ownership remains strong at 80%. Analysts maintain a Moderate Buy rating, with expectations of continued earnings growth and potential inclusion in the Dividend Aristocrats Index.
In contrast, Ionis Pharmaceuticals (NASDAQ: IONS) is experiencing significant insider and institutional selling, despite analysts projecting a 25% upside driven by the anticipated success of its drug Olezarsen. Institutional ownership exceeds 90%, and recent profit-taking may weigh on the stock in the short term. However, analysts remain optimistic, forecasting a strong growth trajectory for the company as it approaches profitability in 2028.
For market professionals, these developments present potential entry points: Waste Management offers a stable dividend and growth, while Ionis could provide substantial upside if its pipeline materializes as expected.
Source: insidertrades.com